1 aug. 2024
Cyclomics announces announce the expansion of the team with the addition of Marc Pagès Gallego to boost ML and AI applications based on Cyclomics' technologies.
We are eager to announce the expansion of the team with the addition of Marc Pagès Gallego. He has joined Cyclomics after a successful tenure as a PhD student at the Department of Center for Molecular Medicine of the UMC Utrecht with the De Ridder group. Here Marc co-created Sturgeon, a state of the art brain tumor classification method using real time sequencing data analysis and machine learning. The resulting paper was published in Nature.
“I am really excited to bring AI to Cyclomics to provide the most accurate and fastest diagnostics” Says Marc.
“Marc’s expertise with AI in a clinical setting is of great value to drive innovation within a wide range of projects at Cyclomics. His ability to work with data containing the complexities of biology will be instrumental for future innovation at Cyclomics. Overall he is a great addition to the team.” says Dami Rebergen, Director of IT & Bioinformatics